Literature DB >> 15471388

[Efficacy and safety of hydrogen sulfide balneotherapy in ischemic heart disease the arid zone].

Z R Zunnunov.   

Abstract

AIM: To evaluate efficacy of hydrogen sulfide (HS) balneotherapy in patients with coronary heart disease (CHD) in conditions of heat discomfort.
MATERIAL AND METHODS: The study included 72 CHD patients aged 35 to 60 years with stable angina pectoris of the second functional class taking balneotherapy in summer under arid climatic conditions. Before and after balneotherapy the patients were examined with estimation of clinical symptoms, stress bicycle exercise (SBE) parameters, number of nitroglycerine tablets.
RESULTS: The balneotherapy resulted in a significant prolongation of SBE (p < 0.0018), in longer time to depression of the ST segment by 1 mm (p < 0.01), to an anginal attack in the course of SBE (p < 0.0036), shorter duration of pain after SBE (p < 0.001), less number of anginal attacks (p < 0.0002) and reduced need in short-acting nitrates (p < 0.0002).
CONCLUSION: In a hot climate of the arid zone use of moderate HS baths raises tolerance of CHD patients to exercise, attenuates clinical manifestations of CHD and, consequently, reduces daily need in nitrates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471388

Source DB:  PubMed          Journal:  Ter Arkh        ISSN: 0040-3660            Impact factor:   0.467


  4 in total

1.  Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide.

Authors:  Fadi N Salloum; Vinh Q Chau; Nicholas N Hoke; Antonio Abbate; Amit Varma; Ramzi A Ockaili; Stefano Toldo; Rakesh C Kukreja
Journal:  Circulation       Date:  2009-09-15       Impact factor: 29.690

Review 2.  Hydrogen sulfide, the next potent preventive and therapeutic agent in aging and age-associated diseases.

Authors:  Yuan Zhang; Zhi-Han Tang; Zhong Ren; Shun-Lin Qu; Mi-Hua Liu; Lu-Shan Liu; Zhi-Sheng Jiang
Journal:  Mol Cell Biol       Date:  2013-01-07       Impact factor: 4.272

Review 3.  Therapeutic application of hydrogen sulfide donors: the potential and challenges.

Authors:  Dan Wu; Qingxun Hu; Yizhun Zhu
Journal:  Front Med       Date:  2015-11-23       Impact factor: 4.592

4.  Hydrogen sulfide attenuates the recruitment of CD11b⁺Gr-1⁺ myeloid cells and regulates Bax/Bcl-2 signaling in myocardial ischemia injury.

Authors:  Youen Zhang; Hua Li; Gang Zhao; Aijun Sun; Nobel C Zong; Zhaofeng Li; Hongming Zhu; Yunzeng Zou; Xiangdong Yang; Junbo Ge
Journal:  Sci Rep       Date:  2014-04-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.